Skip to Main Content
Our Commitment to Diversity

CLE

Webinar

Share via LinkedIn
Share via Twitter
Share via Facebook

COVID-19: The Impact on Litigation in the Pharmaceutical Industry and Mitigating Risk with Litigation Finance

Date: September 2020
Watch Now

This program features a discussion on how COVID-19 has impacted the of pharmaceutical and medical product supply chains. Presenters discuss technology trends on pharmaceutical operations, nature of potential disputes, force majeure, and other key topics.

  • Pharma industry disputes and impact of operations
  • Litigation effect on federal operations -- future disputes likely to result from related business disruption
  • Impact on federal court and other agencies, including FDA and USPTO
  • Applying litigation finance to pharma and life sciences
Find more items tagged as: Health Care Sector, Intellectual Property, Litigation and Dispute Resolution, Pharma and BioPharma Litigation, Pharmaceuticals, Biologics, and Medical Devices, Responding to COVID-19
Watch Now
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel